Related references
Note: Only part of the references are listed.Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria
Judy Savige et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2021)
A multicenter, randomized, placebo -controlled, double-blind phase 3 trial with open -arm comparison indicates safety and ef fi cacy of nephroprotective therapy with ramipril in children with Alport ? s syndrome see commentary
Oliver Gross et al.
KIDNEY INTERNATIONAL (2020)
Trimerization and Genotype-Phenotype Correlation of COL4A5 Mutants in Alport Syndrome
Misato Kamura et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Genotype-phenotype correlations in fl uence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome
Tomohiko Yamamura et al.
KIDNEY INTERNATIONAL (2020)
A review of clinical characteristics and genetic backgrounds in Alport syndrome
Kandai Nozu et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2019)
Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome
Tomoko Horinouchi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases
Gemma Bullich et al.
KIDNEY INTERNATIONAL (2018)
X-linked Alport syndrome: pathogenic variant features and further auditory genotype-phenotype correlations in males
Xiao Zhang et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome
Dominic Cosgrove et al.
MATRIX BIOLOGY (2017)
Natural History and Genotype-Phenotype Correlation in Female X-Linked Alport Syndrome
Tomohiko Yamamura et al.
KIDNEY INTERNATIONAL REPORTS (2017)
A Novel Mutation in a Japanese Family with X-linked Alport Syndrome
Yoshifusa Abe et al.
INTERNAL MEDICINE (2016)
Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy
Stefanie Weber et al.
PEDIATRIC NEPHROLOGY (2016)
X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations
Judith Savige et al.
PLOS ONE (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Splicing inhibition of U2AF65 leads to alternative exon skipping
Sunghee Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A female with X-linked Alport syndrome and compound heterozygous COL4A5 mutations
Mardhiah Mohammad et al.
PEDIATRIC NEPHROLOGY (2014)
Skin Biopsy Is a Practical Approach for the Clinical Diagnosis and Molecular Genetic Analysis of X-Linked Alport's Syndrome
Fang Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
Oliver Gross et al.
KIDNEY INTERNATIONAL (2012)
The Value of Clinical Criteria in Identifying Patients with X-Linked Alport Syndrome
Helen Hanson et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Spliceosome Structure and Function
Cindy L. Will et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Genotype-Phenotype Correlation in X-Linked Alport Syndrome
Mir Reza Bekheirnia et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Mutant-type α5(IV) collagen in a mild form of Alport syndrome has residual ability to form a heterotrimer
Takehiro Kobayashi et al.
PEDIATRIC NEPHROLOGY (2010)
Novel roles of U1 snRNP in alternative splicing regulation
Emanuele Buratti et al.
RNA BIOLOGY (2010)
The Spliceosome: Design Principles of a Dynamic RNP Machine
Markus C. Wahl et al.
CELL (2009)
In vivo and in vitro splicing assay of SLC12A1 in an antenatal salt-losing tubulopathy patient with an intronic mutation
Kandai Nozu et al.
HUMAN GENETICS (2009)
Molecular testing for adult type Alport syndrome
Genevieve Pont-Kingdon et al.
BMC NEPHROLOGY (2009)
Mutational analysis of type IV collagen α5 chain, with respect to heterotrimer formation
Takehiro Kobayashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5′ splice sites
Kentaro Sahashi et al.
NUCLEIC ACIDS RESEARCH (2007)
X-linked Alport syndrome:: Natural history and genotype-phenotype correlations in girls and women belonging to 195 families:: A European community Alport syndrome concerted action study
JP Jais et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Characterization of assembly of recombinant type IV collagen alpha 3, alpha 4, and alpha 5 chains in transfected cell strains
T Kobayashi et al.
KIDNEY INTERNATIONAL (2003)
Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling
O Gross et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Mechanisms of fidelity in pre-mRNA splicing
R Reed
CURRENT OPINION IN CELL BIOLOGY (2000)
Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
E Ars et al.
HUMAN MOLECULAR GENETICS (2000)
Alport syndrome: Abnormalities of type IV collagen genes and proteins
CE Kashtan
RENAL FAILURE (2000)
Share Paper
